GUANGZHOU, China, Oct. 16, 2013 /PRNewswire/ -- On September 3, 2013, Shanghai Fosun Pharmaceutical (Group) Co., Ltd purchased a 50% stake in Guangzhou Nanyang Tumour Hospital. After the cooperation with Shanghai Fosun Pharmaceutical (Group) Co., Ltd, Guangzhou Nanyang Tumour Hospital has become a major force among high-end international tumour hospitals.
In recent years, Fosun Pharma has actively developed medical services and has successively purchased many well-known hospitals at home and abroad. It is also devoted to building an international medical aircraft carrier. The share acquisition of Guangzhou Nanyang Tumour Hospital is an especially important strategic move, by which Fosun Pharma expects that the high-level tumour medical services and extensive international influence of Guangzhou Nanyang Tumour Hospital could be helpful for its entrance into the field of international tumour medical treatment from a higher starting point. The series of acquisitions reflect the extraordinary strategic vision of Shanghai Fosun Pharmaceutical (Group) and its focus on international medical treatment.
Guangzhou Nanyang Tumour Hospital is an international authoritative tumour specialized hospital which is well-known in the world and has gained a solid reputation in both the Asia-Pacific and Western countries. The hospital was founded by Sun Yan, who was the founder of China's medical oncology and a member of the Chinese Academy of Engineering. He was subsequently awarded the Tenured Honorary President of the hospital. The hospital gathers many leading tumour experts from around the world, including professor Nakamura Hironobu from Osaka University in Japan, professor Luo Pengfei who is China's chief tumour expert on minimally invasive therapy, professor Li Peiwen who is a famous tumour expert on combined treatment of traditional Chinese medicine and Western medicine and Drs. Szeto and Jerkins who are well-known American experts, etc. The senior management team includes many well-known Japanese medical management experts and US doctors. The hospital insists on carrying out a standardized Japanese international medical management system and has won high praise from all over the world.
It's worth mentioning that the hospital is known as an innovative place for post-doctorate research in Guangdong Province and Guangzhou City. Undoubtedly, the strategic cooperation with Fosun Pharma will further promote the standing of both parties in the international medical field and quicken the pace of the global development of Guangzhou Nanyang Tumour Hospital.
